Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

For diabetes control, surgery and intensive lifestyle change about equal

A diabetic tests his blood sugar level in Vienna November 13, 2012. Picture taken November 13. Reuters/Heinz-Peter Bader (Reuters Health) – Intensive medical management with supervised diet and exercise may work as well as weight-loss surgery to help diabetics get blood sugar levels under control, at least in the short term, a small study suggests. […]

Read More »

Study shows measles vaccine thwarts other infectious diseases

(Reuters) – The measles vaccine provides benefits beyond merely protecting against that highly contagious viral respiratory disease that remains a leading childhood killer in parts of the world, scientists say. By blocking the measles infection, the vaccine prevents measles-induced immune system damage that makes children much more vulnerable to numerous other infectious diseases for two […]

Read More »

Fake, low-grade drugs hinder drive against disease, weaken trust: researchers

  LONDON (Thomson Reuters Foundation) – Fake and low-quality drugs hinder efforts to tackle disease, weaken public trust in national health systems and raise questions over governance, drug researchers said on Thursday. The proliferation of drugs which fail to work properly creates a “spiral of distrust” that undermines the legitimacy of public health systems, especially […]

Read More »

Device to Sand Away Severe Calcium in Coronary Arteries Shows Long-Term Positive Results in a Difficult-to-Treat Patient Population

SAN DIEGO, May 7, 2015 /PRNewswire/ — After two years, patients treated with orbital atherectomy, a device that sands away severely calcified plaque in the coronary arteries prior to stenting, continued to show positive results, according to new data from the ORBIT II trial presented today as a late-breaking clinical trial at the Society for Cardiovascular […]

Read More »

Combined Blood Pressure and LDL Cholesterol-Lowering Medication Therapy Reduces Harmful Coronary Plaque

SAN DIEGO, May 7, 2015 /PRNewswire/ — Treating both low-density lipoprotein (LDL), or “bad,” cholesterol with statins and blood pressure with calcium channel antagonists reduces harmful coronary plaque, according to a new study presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions in San Diego. The […]

Read More »

Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports First Quarter 2015 Financial Results

Conference Call and Webcast Today, May 7, 2015 at 4:30 p.m. Eastern Time ANN ARBOR, MI–(Marketwired – May 07, 2015) – Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today provided […]

Read More »

La Jolla Pharmaceutical Company Announces Portfolio Reprioritization

SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced a reprioritization of its product development programs. As a result of this reprioritization, La Jolla will discontinue development of its polysaccharide-based […]

Read More »

La Jolla Pharmaceutical Company Acquires Rights to Next-Generation Gentamicin Derivatives

SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that it has entered into an exclusive option agreement to acquire the Indiana University Research and Technology Center’s (IURTC) intellectual property […]

Read More »

Deviated noses may be harder to correct than first thought

(Reuters Health) – People who have crooked, or “deviated,” noses are more likely to have a face whose two sides don’t quite match up either, suggests a new study from South Korea. More than half of the people with deviated noses that the researchers examined had facial asymmetry, compared to about a third of people […]

Read More »

AbbVie (ABBV), Genentech (RHHBY) Leukemia Drug Wins Breakthrough Status Tag

A promising new blood cancer therapy from AbbVie (ABBV) and Genentech (RHHBY) that snagged headlines in early December for unexpectedly high rates of response in clinical trial patients has now been granted breakthrough status from the U.S. Food and Drug Administration (FDA), the companies said Thursday. The investigational drug, dubbed venetoclax, is an inhibitor of […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom